Fenwick & West

Who owns innovation when AI takes the reins? ?? Hear from Fenwick’s Antonia Sequeira and Fredrick Tsang as they dive into the game-changing?Thaler v. Vidal?decision and what it means for the future of life sciences and technology patents. ?? Only humans can be inventors on patents. But it leaves a big question open: what happens when AI and humans team up on an idea? ?? AI alone doesn’t qualify as an inventor—human involvement is essential. ?? AI is shaking up drug discovery, cutting timelines by 30%, and enabling breakthroughs in genomic analysis. Their advice? Bring legal counsel into the fold early to keep your IP strategy sharp in this evolving frontier. #AI #Innovation #FenwickforLifeSciences

Attention 1L Students! ?? We are thrilled to announce applications are now open for our 1L Scholarship Program and 1L Tax Hiring for Summer 2025! ?? Interested in high-tech and life sciences? This is your chance to join a dynamic team tackling sophisticated legal challenges while gaining hands-on experience and advancing your professional development. Apply here to be part of our innovative legal practice: https://lnkd.in/eBTQA2h #1L #LegalCareer #LawStudents?

?? Catch up on the latest securities news before you unplug for a well-deserved holiday and relax knowing you’re prepped for the weeks ahead! Check out the latest edition of Fenwick’s Securities Law Update for important updates and reminders on: ?? Form 10-K and proxy statement disclosures and upcoming compliance deadlines? ??? New proxy voting guidelines from Glass Lewis? ??? A pause to Public Company Accounting Oversight Board rulemaking? ??? Important SEC enforcement matters? ?? Changes to SEC filer access and account management Read the full update here: https://lnkd.in/eqSkr4ET #Securities #PublicCompanies #CorporateLaw?

Celebrating collaboration and the founder-funder community! Last week, Fenwick hosted a dinner with Failup Ventures during Slush 2024. Fenwick’s Kat Duncan and Allison Cooper joined an inspiring group of founders and funders, including Jesse Heikkil? and Topias Soininen from Failup, for candid discussions and meaningful connections. Here’s to the ideas and relationships driving innovation forward. #Slush2024 #Founders #Funders

Come behind the scenes with partner Douglas Cogen, one of this year's Law360 Life Sciences MVPs, to understand how Fenwick’s M&A team carried some of this year’s historic life sciences deals into the end zone. Highlights include: ? Alpine Immune Sciences, Inc. acquired by Vertex Pharmaceuticals for $4.9 billion? ? Shockwave Medical acquired by Johnson & Johnson for $13.1 billion Doug serves as lead lawyer on pivotal M&A transactions for his clients—but it’s really a team sport.? Like a conductor or a coach, Doug assembles the best team to enable clients to reach their business goals and to let every person on the deal shine.? Congrats, Doug, on being named MVP! Read more in his Law360 Q&A: https://lnkd.in/ef3zirBS #FenwickforLifeSciences #MergersAndAcquisitions #LegalAwards

AI is reshaping drug discovery—but could it put your IP rights at risk? As life sciences companies increasingly rely on AI, questions around invention ownership are becoming more pressing.?#ICYMI Fenwick's Antonia Sequeira, Carl Morales, and Fredrick Tsang explored how evolving IP laws could influence AI-driven breakthroughs, from patent eligibility to M&A diligence. ????Stay ahead in the evolving IP landscape: https://lnkd.in/dEgFKEiR #FenwickforLifeSciences #AI

Employers: Proposed new rules expanding who's eligible for overtime won’t be going into effect after all, now that a Texas federal court has vacated the controversial Department of Labor rule that would have raised the minimum salary threshold to exempt executive, administrative, and professional employees nationwide. ?? Read the latest from Matthew Damm and Reanne Swafford-Harris to find out what comes next: https://lnkd.in/d2WBmWxT

Late-stage biotech leaders, are you ready for what’s next? Join us for Pathways to Success, our three-part webinar series designed for late-stage biotech leaders preparing for their next big move. From strategic IPO planning to the trends shaping 2025’s M&A landscape, each session will offer actionable strategies tailored to the unique challenges of life sciences companies. ?? Mitchell Gold M.D., CEO of Alpine Immune Sciences, Inc., will reflect on Alpine’s $4.9 billion acquisition and shares leadership lessons with Fenwick partners Effie Toshav and Douglas Cogen. ??Fenwick and Morgan Stanley leaders are set to explore IPO readiness and the key steps life sciences companies should take to prepare. ??Discover the M&A trends reshaping the life sciences industry in the year ahead. ?? Take the next step in preparing your company for pivotal transitions. Register for the first session: https://lnkd.in/du5dsX_i #biotech #latestage #FenwickforLifeSciences

Blockchain is transforming industries—and the tax world is no exception. ? Fenwick tax partner David Forst and associate Sean P. McElroy dive into the complex intersection of blockchain and taxation in their chapter for Global Legal Insights (GLI). They break down topics like hard forks, staking, airdrops, and DAOs, navigating limited IRS guidance and exploring key questions surrounding newly created tokens and DeFi. ? Discover how traditional tax principles are evolving to meet the demands of revolutionary technology: https://lnkd.in/eSSHb8jg ? #Blockchain #Tax #Crypto

We're so proud to facilitate these important conversations around decarbonization, energy transition, the built environment, supply chain optimization, and climate finance with Remarkable Ventures Climate. ? Thanks to the founders and investors who joined us! We’re excited to see how this community continues collaborating and driving innovation toward a sustainable future! #Startups #ClimateTech #Sustainability?